Particularly, inhibition of UHRF1, a key epigenetic regulator coordinating DNA methylation and histone modifications, sensitizes retinoblastoma cells to HDAC inhibitors, suggesting novel therapeutic avenues targeting this interplay [31]. This evidence concerns the gene UHRF1 and retinoblastoma.